专利号:US-9833457-B2 优先权日:2008-01-25 标题:Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors 发明人:MJALLI ADNAN M M; GADDAM BAPU; POLISETTI DHARMA RAO; KOSTURA MATTHEW J; GUZEL MUSTAFA 权利人:VTV THERAPEUTICS LLC 摘要:The present invention relates to chemical compounds of Formula (I) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of conditions or disorders mediated by TNF-α or by PDE4, including but not limited to psoriatic arthritis.
专利号:US-5403898-A 优先权日:1992-05-04 标 题:Single arm attached cyclodextrin polysiloxanes and use thereof as chiral stationary phases in chromatographic separation of enantiomers 发明人:BRADSHAW JERALD S; LEE MILTON L; ROSSITER BRYANT E 权利人:UNIV BRIGHAM YOUNG 摘要:Cyclodextrin containing polymeric siloxanes wherein the cyclodextrin is connected to the polymeric siloxane by a single linking member connected to the 2, 3 or 6-position of the cyclodextrin are disclosed. These polymers are chemically and thermally stable to gas, supercritical fluid chromatographic conditions. The single arm attachment provides cyclodextrin containing polysiloxane polymers having synthesis reproducibility from batch to batch resulting in consistent chromatographic performance of the resulting chiral phases. The use of such polymers as chiral stationary phases in analytical and preparative gas, supercritical fluid and liquid chromatographic separations, and particularly for analysis of enantiomeric and other stereoisomeric mixtures of various substances is shown.
专利号:MX-2010007768-A 优先权日:2008-01-25 标题 :TRICICLIC COMPOUNDS AS MODULATORS OF THE SYNTHESIS OF THE ALFA TUMOR NECROSIS FACTOR AND AS INHIBITORS OF PHOSPHODIESTERASE 4.
专利号:WO-2009094528-A1 优先权日:2008-01-25 标 题:TRICYCLIC COMPOUNDS AS MODULATORS OF TNF-α SYNTHESIS AND AS PDE4 INHIBITORS
专利号:US-2012172381-A1 优先权日:2008-01-25 标题 :Tricyclic Compounds as Modulators of TNF-alpha Synthesis and as PDE4 Inhibitors
专利号:US-2018071297-A1 优先权日:2008-01-25 标题 :Tricyclic compounds as modulators of tnf-alpha synthesis and as pde4 inhibitors